| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cencora, Inc. | Director | Common Stock | 3,194 | $830,632 | $260.06 | 06 Mar 2025 | Direct |
| Adagio Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 44,178 | 22 Jun 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| COR | Cencora, Inc. | 06 Mar 2025 | 1 | $0 | 4 | Director | 10 Mar 2025, 16:29 |
| COR | Cencora, Inc. | 12 Mar 2024 | 1 | $0 | 4 | Director | 13 Mar 2024, 16:15 |
| COR | AMERISOURCEBERGEN CORP | 09 Mar 2023 | 1 | $0 | 4 | Director | 13 Mar 2023, 16:19 |
| COR | AMERISOURCEBERGEN CORP | 01 Feb 2023 | 1 | $0 | 4 | Director | 03 Feb 2023, 15:10 |
| COR | AMERISOURCEBERGEN CORP | 01 Jan 2023 | 0 | $0 | 3 | Director | 05 Jan 2023, 15:43 |
| IVVD | Adagio Therapeutics, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 16:32 |
| IVVD | Adagio Therapeutics, Inc. | 19 Nov 2021 | 1 | $0 | 4 | Director | 23 Nov 2021, 17:10 |
| IVVD | Adagio Therapeutics, Inc. | 19 Nov 2021 | 0 | $0 | 3 | Director | 22 Nov 2021, 17:36 |